Further analyses of The Cancer Genome Atlas (TCGA) database showed that high Nrf2 expression was associated with reduced overall survival and shortened disease-free survival in CRC patients (Fig. S4A, B). Here, NFE2L2 is linked to colorectal carcinoma.